[CINCA syndrome. An infrequent systemic process].
López Saldaña
D
D
Sección de Adolescentes, Servicio de Pediatria, Hospital del Niño Jesús, Universidad Autónoma de Madrid.
Ibáñez Rubio
M
M
Brañas Fernández
P
P
Rodríuez Serrano
F
F
López Robledillo
J C
JC
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001177:Arthropathy, Neurogenic / Q000175:diagnosis* / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013577:Syndrome
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000964:Antimetabolites, Antineoplastic; D001241:Aspirin; D011241:Prednisone; D008727:Methotrexate